- Home
- PRPO vs NLSP Comparison
PRPO vs NLSP Comparison
Compare PRPO & NLSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRPO
- NLSP
- Stock Information
- Founded
- PRPO N/A
- NLSP 2015
- Country
- PRPO United States
- NLSP Switzerland
- Employees
- PRPO N/A
- NLSP N/A
- Industry
- PRPO Biotechnology: Laboratory Analytical Instruments
- NLSP Biotechnology: Pharmaceutical Preparations
- Sector
- PRPO Industrials
- NLSP Health Care
- Exchange
- PRPO Nasdaq
- NLSP Nasdaq
- Market Cap
- PRPO N/A
- NLSP 12.4M
- IPO Year
- PRPO N/A
- NLSP 2021
- Fundamental
- Price
- PRPO $16.27
- NLSP $2.31
- Analyst Decision
- PRPO
- NLSP
- Analyst Count
- PRPO 0
- NLSP 0
- Target Price
- PRPO N/A
- NLSP N/A
- AVG Volume (30 Days)
- PRPO 13.9K
- NLSP 378.8K
- Earning Date
- PRPO 08-12-2025
- NLSP 07-15-2025
- Dividend Yield
- PRPO N/A
- NLSP N/A
- EPS Growth
- PRPO N/A
- NLSP N/A
- EPS
- PRPO N/A
- NLSP N/A
- Revenue
- PRPO $20,029,000.00
- NLSP N/A
- Revenue This Year
- PRPO N/A
- NLSP N/A
- Revenue Next Year
- PRPO N/A
- NLSP N/A
- P/E Ratio
- PRPO N/A
- NLSP N/A
- Revenue Growth
- PRPO 26.67
- NLSP N/A
- 52 Week Low
- PRPO $3.90
- NLSP $1.30
- 52 Week High
- PRPO $16.50
- NLSP $15.59
- Technical
- Relative Strength Index (RSI)
- PRPO 82.13
- NLSP 48.87
- Support Level
- PRPO $10.60
- NLSP $2.20
- Resistance Level
- PRPO $11.70
- NLSP $3.08
- Average True Range (ATR)
- PRPO 0.86
- NLSP 0.25
- MACD
- PRPO 0.43
- NLSP -0.05
- Stochastic Oscillator
- PRPO 93.06
- NLSP 16.36
About NLSP NLS Pharmaceutics Ltd.
NLS Pharmaceutics Ltd a clinical-stage biopharmaceutical company focused on the discovery and development of inventive therapies for patients with rare and complex CNS disorders with unmet medical needs. Its compound, mazindol, a triple monoamine reuptake inhibitor and partial orexin receptor 2 agonist, in a proprietary ER formulation, is being developed for the treatment of narcolepsy, IH (follow-on indication), and potentially ADHD (back-up indication). Its lead products are Quilience, to treat narcolepsy and Nolazol, to treat ADHD.